PGHL5,435.00

Procter & Gamble Health Limited

· Pharma & Health
₹ CrorePeersSANOFICONRSANOFISENORESINNOVACAPMOREPENLABIOLCPFDCASTRAZENMcap ₹9,022 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
PGHL
FY27
SANOFICONR
FY26
SANOFI
FY25
SENORES
FY26
Peer
Median
Valuation — at last close
P/E93.84×40.09×17.33×55.63×40.09× +134%
P/B16.76×25.04×8.31×7.01×8.31× +102%
EV/EBITDA88.19×29.90×13.99×41.84×29.90× +195%
Market Cap₹9,022 Cr₹9,614 Cr₹7,153 Cr₹6,760 Cr₹7,153 Cr +26%
Growth
Revenue CAGR 3Y-33.37%
Revenue CAGR 5Y-18.46%
Net Income CAGR 3Y-25.17%
Revenue YoY (latest Q)7.37%6.70%-25.80%30.60%6.70% +10%
Net Income YoY (latest Q)45.29%13.34%-33.70%43.77%13.34% +240%
Profitability
EBITDA Margin27.38%35.18%24.38%26.61%26.61% +3%
Net Income Margin26.44%27.33%20.53%19.21%20.53% +29%
Return on Common Equity17.86%62.53%48.02%12.60%48.02% -63%
Return on Capital Employed16.26%71.02%50.87%11.62%50.87% -68%
Return on Assets12.10%43.89%25.64%7.58%25.64% -53%
Credit & Quality
Total Debt/Equity0.00×0.00×0.00×0.34×0.00×
Interest Coverage668.43×148.65×302.73×5.48×148.65× +350%
Scale — latest FY
Revenue / Total Income₹364 Cr₹878 Cr₹2,013 Cr₹633 Cr₹878 Cr -59%
Net Income₹96.2 Cr₹240 Cr₹413 Cr₹122 Cr₹240 Cr -60%
Total Assets₹547 Cr₹1,612 Cr₹1,604 Cr₹1,604 Cr
EPS₹57.92₹104.27₹179.46₹26.39₹104.27 -44%
Book Value per Share₹324.24₹166.96₹374.17₹209.45₹209.45 +55%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.